Loading clinical trials...
Loading clinical trials...
A Prospective, Multi-Center Investigational Study of Heart Rate Variability Monitoring for the Early Detection of Pancreatic Cancer
Conditions
Interventions
Activity Monitor
Quality-of-Life Assessment
+1 more
Locations
3
United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York, United States
OHSU Knight Cancer Institute
Portland, Oregon, United States
Start Date
September 21, 2020
Primary Completion Date
September 30, 2022
Completion Date
September 30, 2022
Last Updated
November 22, 2022
NCT02600949
NCT06921928
NCT06423326
NCT07542041
NCT06821997
NCT07076121
Lead Sponsor
OHSU Knight Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions